IRF5: A Novel Mechanism in High Unmet Need Indications in I&I

        >10M                 Systemic Advanced
                                                  RHEUMATOLOGY

                                                      RA
                                                                  PATIENTS1


                                                                     4.7M
                               Therapies: 7%          Lupus2         1.2M
                                                      SjÃ¶gren's      765K
                                   >$45B Market       SSc            200K
     TOTAL POTENTIAL                                  DM             >100K
     PATIENT IMPACT1
                                                  GASTROENTEROLOGY
IRF5 functional risk variants associate with
increased susceptibility to multiple diseases,        UC             1.9M
and IRF5 regulated pathways have been
clinically validated by multiple drugs
                                                      CD             1.5M

                                                                              41
